Abbvie INC ABBVIE ORD SHS
Abbvie INC ABBVIE ORD SHS/ US00287Y1091 /
0QCV
24/05/2024 16:45:26
|
Var.
-
|
Volume |
Denaro18:30:00 |
Lettera18:30:00 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
158.01USD
|
-
|
5,627 Fatturato: - |
-Quantità in denaro: - |
-Quantità in lettera: - |
343.18 bill.USD |
3.08% |
71.17 |
Descrizione business
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Richard A. Gonzalez |
Consiglio di amministrazione |
Scott T. Reents, Carrie Strom, Dr. Azita Saleki-Gerhardt, Jeffrey R. Stewart, Perry C. Siatis, Rae L. Livingston, Robert A. Michael, Timothy J. Richmond, Kevin Buckbee, Nicholas Donoghoe, Tracie Haas, Thomas Hudson, Greg Miley, Elaine K. Sorg |
Consiglio di sorveglianza |
Richard A. Gonzalez, Brett J. Hart, Edward J. Rapp, Frederick H. Waddell, Glenn F. Tilton, Melody B. Meyer, Rebecca B. Roberts, Robert J. Alpern, Roxanne S. Austin, Thomas Freyman, William H.L. Burnside |
Dati aziendali
Name: |
AbbVie Inc. |
Indirizzo: |
1 North Waukegan Road,North Chicago, Illinois 60064-6400, USA |
Telefono: |
+1-847-932-7900 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.abbvie.com/ |
Industria: |
Healthcare |
Settore: |
Pharmaceutical Industry |
Sub settore: |
Pharmaceuticals |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
96.70% |
Data dell'IPO: |
02/01/2013 |
Rapporti con gli investitori
Name: |
Liz Shea |
IR telefono: |
+1-847-935-2211 |
IR Fax: |
- |
IR e-mail: |
liz.shea@abbvie.com
|
Company calendar
CW 42 | 15/10/2024
Ex-Dividend
|
CW 42 | 15/10/2024
Record Date
|
CW 46 | 15/11/2024
Dividend Payment
|